The NHS in England is set to offer the anti-smoking pill Varenicline to help smokers quit, as it has been shown to be as effective as vapes in reducing cravings for nicotine and withdrawal symptoms. This new treatment option, when combined with behavioral support, has the potential to help one in four people quit smoking for at least six months, potentially saving thousands of lives and millions of pounds in treatment costs. NHS Chief Executive Amanda Pritchard highlights the importance of this initiative in addressing the public health issue of smoking and supporting the government’s goal of creating a smoke-free generation.
Full Article
Loading PerspectiveSplit analysis...
